Aziyo Biologics to Participate in the Lytham Partners Spring...| MENAFN.COM

Wednesday, 06 July 2022 12:48 GMT

Aziyo Biologics to Participate in the Lytham Partners Spring 2022 Investor Conference


(MENAFN- GlobeNewsWire - Nasdaq)

SILVER SPRING, Md., March 31, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022.

The Company's webcast presentation will be available for viewing at 11:00am ET on Monday, April 4, 2022, on the Company's website at . The webcast will also be archived and available for replay.

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at or register at .

About Aziyo Biologics

Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit .

Investors:
Leigh Salvo
Gilmartin Group




Related Links

MENAFN31032022004107003653ID1103946692


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.